| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months (pa) | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | The quantitative model is proprietary and designed in-house. The critical elements are Valuation, Momentum, and Quality (VMQ) and every stock in the global universe is scored and ranked. Verification of the quant model scores is then cross checked by fundamental analysis in which a company's Accounting policies, Governance, and Strategic positioning is evaluated. The manager believes strategy is suited to investors seeking returns from investing in global companies, diversification away from Australia and a risk aware approach to global investing. It should be noted that this is a strategy in an IMA format and is not offered as a fund. An IMA solution can be a more cost and tax effective solution, for clients who wish to own fewer stocks in a long only strategy. |
| Manager Comments | Delft noted their philosophy of not timing market exposure has helped them capture much of the market's recent rebound. They remain diversified with underweight positions in banks and oils, and overweight positions in 'true technology' companies such as KLA Tencor. Delft have a positive view of Japan and Asia which performed strongly in the market's rebound. During the quarter Delft sold Cisco and reinvested in Ciena Corp in the USA. They also sold Celanese Corp and reinvested in Bristol Myers. Notable price changes came from Hong Kong Exchange, KLA Tencor and General Mills. The Strategy remains unhedged for AUD$ based investors. |
| More Information |
